Deferasirox
- Product NDC
- 67877-553
- 11-digit product format
- 678770553
- Labeler code
- 67877
- Product ID
- 67877-553_5e8c386f-5879-4f68-bc6f-38041072f5ad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA210555
- Marketing category
- ANDA
- Marketing start
- 2020-07-04
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V8G4MOF2V9 | DEFERASIROX | 201530-41-8 | DEFERASIROX |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 67877-553-30 | 67877055330 | 30 TABLET, FILM COATED in 1 BOTTLE (67877-553-30) | 2020-07-04 | No | No | Historical |
| 67877-553-90 | 67877055390 | 90 TABLET, FILM COATED in 1 BOTTLE (67877-553-90) | 2020-07-04 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Deferasirox | Ascend Laboratories, LLC | Alkem Laboratories Limited | 2025-06-04 | Human Prescription Drug Label | 13 |